Articles
2 de July de 2024
Life Sciences’ Brazil Global Guide 2024 is now available
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide!
Our partners Priscila Kashiwabara and Viviane Trojan, along with attorneys at law Gustavo Vicenti and Giovanna Verginelli Mezher, authored the Life Sciences 2024 guide for Brazil, that outlines the regulatory framework for pharmaceuticals and medical devices, detailing the legislation, regulatory bodies and procedures for securing approvals and handling appeals. It covers categorisation, clinical trials, marketing authorizations and ongoing obligations.
The guide also emphasizes ANVISA’s role in regulation, the stringent requirements for biologics and the procedures for compassionate use and post-marketing surveillance. Additionally, it addresses manufacturing authorizations, distribution regulations and measures against counterfeit products.
For more details, click here.
Share:
Last related news
14 de September de 2026
Guidance Note: Brazil – Direct Marketing
Partner Claudio Barbosa and Attorney at Law Larissa Martins have recently authored the article “Data Guidance: Brazil – Direct Marketing” for the … Guidance Note: Brazil – Direct Marketing
8 de July de 2026
SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements
ABSTRACT: The increasing judicialization of disputes involving Standard Essential Patents (SEPs) has shifted the focus of legal debate beyond the mere assessment … SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements
28 de January de 2026
Data Protection Day: Between Regulatory Maturity and the New Challenges of Artificial Intelligence
Data Protection Day, celebrated on January 28, goes beyond symbolism. Each year, the date reinforces the consolidation of personal data protection, with … Data Protection Day: Between Regulatory Maturity and the New Challenges of Artificial Intelligence